Acorda Therapeutics, Inc. (ACOR)の価格はいくらですか

Acorda Therapeutics, Inc. (ACOR)の価格は$0.879です

Acorda Therapeutics, Inc. (ACOR)の時価総額は何ですか

Acorda Therapeutics, Inc. (ACOR)の時価総額は$582.38Kです

Acorda Therapeutics, Inc.（ACOR）EPS（1株当たり利益）

Acorda Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing treatments for conditions affecting the nervous system, primarily within the United States. Its current product offerings include Ampyra (dalfampridine), an oral medication prescribed to enhance walking ability in individuals with multiple sclerosis (MS). The company also distributes Inbrija in Europe, which is used to manage "OFF" periods experienced by Parkinson's disease patients. Globally, Ampyra is recognized and sold as Fampyra across Europe, Asia, and the Americas. Beyond its existing products, Acorda is actively advancing several experimental therapies: ARCUS for the management of acute migraine attacks, rHIgM22 which has successfully completed Phase I clinical trials for MS, and Cimaglermin alfa, currently being investigated for patients with heart failure. The company holds a licensing and collaborative agreement with Biogen Inc. for the ongoing development and market distribution of Ampyra. Acorda Therapeutics, Inc. was founded in 1995 and operates from its headquarters in Ardsley, New York.

年	EPS	変化
提供された日付のデータは十分ではありません。

年

EPS

変化

提供された日付のデータは十分ではありません。

企業	EPS	EPSの差	国
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$0.56	-	IN

企業

EPS

EPSの差

国